Baxter International Inc. Common Stock (BAX)
Stock · NYSE · Health Care
$25.28as of 10/16/2026
Price chart
Active signals
BAX Signal Track Record
How signals performed across all stocks →What BAX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 30 | -1.9% | 43% | September 16, 2026 |
| Bollinger Band Breakdown | 20 | -2.3% | 25% | September 8, 2026 |
| Bollinger Band Breakout | 20 | +1.7% | 55% | July 28, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -1.4% | 45% | June 22, 2026 |
| Any 20-session window (baseline) | -1.4% | 44% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About BAX
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgi…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 37,500
- Website
- www.baxter.com/
Fundamentals
- 1-day range
- $25.13$25.99
- Market cap
- $13.96B
- P/E (trailing)
- —
- P/E (forward)
- 12.39
- EPS (trailing)
- $-2.07
- Dividend yield
- 3.22%
- Beta
- 0.67
- Avg. volume
- 6.51M
- Ex-dividend date
- August 28, 2026
- Dividend pay date
- October 1, 2026
How Baxter International Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 12, 2026 · via SEC EDGAR / Finnhub
Forecasts
12 analyst ratings
Baxter International Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- BAXBaxter International Inc. Common Stock$25.28▼ 1.86%Market cap $13.96BP/E —$15.73$30
- GMEDGlobus Medical Inc. Class A Common Stock$76.71▼ 2.70%Market cap $11.01BP/E 19.14$56.96$101.4
- GKOSGlaukos Corporation Common Stock$164.84▼ 0.46%Market cap $10.09BP/E —$73.16$191.62
- PODDInsulet Corporation Common Stock$141.1▲ 1.68%Market cap $9.65BP/E 25.40$126.4$354.88
- TFXTeleflex Incorporated Common Stock$130.43▲ 1.72%Market cap $6.15BP/E —$100.18$145
- STVNStevanato Group S.p.A. Ordinary Shares$18.9▼ 1.82%Market cap $6.14BP/E 34.82$12.89$27.99
- MMSIMerit Medical Systems Inc. Common Stock$89.2▼ 0.41%Market cap $5.24BP/E 36.22$59.74$94.75
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BAX Baxter International Inc. Common Stock | $13.96B | — | $25.28 | ▼ 1.86% | $15.73$30 |
| GMED Globus Medical Inc. Class A Common Stock | $11.01B | 19.14 | $76.71 | ▼ 2.70% | $56.96$101.4 |
| GKOS Glaukos Corporation Common Stock | $10.09B | — | $164.84 | ▼ 0.46% | $73.16$191.62 |
| PODD Insulet Corporation Common Stock | $9.65B | 25.40 | $141.1 | ▲ 1.68% | $126.4$354.88 |
| TFX Teleflex Incorporated Common Stock | $6.15B | — | $130.43 | ▲ 1.72% | $100.18$145 |
| STVN Stevanato Group S.p.A. Ordinary Shares | $6.14B | 34.82 | $18.9 | ▼ 1.82% | $12.89$27.99 |
| MMSI Merit Medical Systems Inc. Common Stock | $5.24B | 36.22 | $89.2 | ▼ 0.41% | $59.74$94.75 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Baxter (BAX) Stock May Be 30% Undervalued On Cash FlowYahoo · 10/9/2026
- Barclays Initiates Coverage of Baxter International at UnderweightFintel · 10/7/2026
- Baxter to Host Third-Quarter 2026 Financial Results Conference Call for InvestorsYahoo · 10/7/2026
- Intel downgraded, Marvell upgraded: Wall Street's top analyst callsYahoo · 10/7/2026
- Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?Yahoo · 10/6/2026
- Are Investors Undervaluing Baxter International (BAX) Right Now?Yahoo · 10/6/2026
- Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™Yahoo · 10/5/2026
- 3 of Wall Street’s Favorite Stocks with Warning SignsYahoo · 10/1/2026
- Top 3 Health Care Stocks That May Rocket Higher In Septemberbenzinga · 9/21/2026
Insider Activity
Insider Actions →- Andrew P. Hider · September 2, 2026 · Tax Withholding54.3K @ $25.7
- Foster Julie · September 2, 2026 · Tax Withholding2.1K @ $25.7
- James Teaff · September 1, 2026 · Tax Withholding750 @ $25.48
- Steven P. Wallace · June 2, 2026 · Tax Withholding153 @ $18.68
- James Teaff · June 2, 2026 · Tax Withholding321 @ $18.68
- Anita A. Zielinski · June 1, 2026 · Grant13.4K
- David S. Wilkes · May 5, 2026 · Grant12.8K
- Amy McBride Wendell · May 5, 2026 · Grant12.8K
- David Brent Shafer · May 5, 2026 · Grant12.8K
- McDonnell Michael R. · May 5, 2026 · Grant12.8K
- Jeffrey A. Craig · May 5, 2026 · Grant12.8K
- William A. Ampofo II · May 5, 2026 · Grant12.8K
- Nancy M. Schlichting · May 5, 2026 · Grant12.8K
- Patricia Morrison · May 5, 2026 · Grant12.8K
Institutional Ownership
March 31, 2026
- Total shares held
- 506.33M
- Total value held
- $8.28B
- Institutional holders
- 656
- Unknown79.40M
- Unknown64.53M
- Unknown57.25M
- Unknown46.26M
- Unknown33.51M
- Unknown19.98M
- Unknown14.31M
- Unknown13.76M
- Unknown13.12M
- Unknown7.35M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Baxter International publishes inaugural Connected Hospital Report
Baxter International released its first Connected Hospital Report, highlighting its role in remote cardiac monitoring and digital health infrastructure. The company is also featured in recent discussions regarding potential warning signs in Wall Street favorites and overlooked investment angles. These developments provide context for the stock's current position within its 52-week range.
Baxter International publishes inaugural Connected Hospital Report. Baxter International released its first Connected Hospital Report, highlighting its role in remote cardiac monitoring and digital health infrastructure. The company is also featured in recent discussions regarding potential warning signs in Wall Street favorites and overlooked investment angles. These developments provide context for the stock's current position within its 52-week range.